Nvidia Unveils AI Microservices for Healthcare Innovation at GTC Conference
March 25, 2024
At its annual GTC conference, Nvidia introduced 25 generative AI microservices aimed at revolutionizing the healthcare sector, particularly benefiting pharmaceutical companies in drug discovery, medical imaging, genomics, and more. Nvidia CEO Jensen Huang highlighted that these services, including enhanced Nvidia NIM AI models and expanded BioNeMo microservices, will be integrated into Amazon Web Services’ health suite. Collaborations with Cadence Pharmaceuticals, Microsoft Azure, and Johnson & Johnson MedTech underscore Nvidia’s commitment to advancing AI in healthcare. Nvidia’s support also facilitates the establishment of a sovereign AI Innovation Center in Denmark with the Novo Nordisk Foundation. This strategic move comes as Nvidia’s market value briefly hit $2 trillion, reflecting the surging investor interest in AI. The company’s healthcare endeavors are not new, with previous partnerships aimed at leveraging generative AI for advancements in cell biology and drug discovery, demonstrating Nvidia’s ongoing dedication to transforming healthcare through AI technology.
To read more, click here.
[Source: MM+M, March 18th, 2024]
